Literature DB >> 9637257

An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly.

A Wörn1, A Plückthun.   

Abstract

A fully functional cysteine-free derivative of the intrinsically stable anti-HER2 scFv fragment hu4D5-8 was generated by replacing the disulfide forming cysteine residues in VH and VL with the amino acid combination valine-alanine in both domains. The antigen binding properties, determined by ELISA and BIAcore measurements, were not affected by removal of the disulfide bonds. The thermodynamic stability of the disulfide-containing scFv of 8.1 kcal/mol is decreased upon complete reduction of both disulfides to 2.7 kcal/mol, while that of the valine-alanine variant is somewhat higher (about 3.8 kcal/ mol). Our results suggest that, in principle, a disulfide-free fully functional derivative of any scFv can be obtained, as long as the corresponding disulfide-containing scFv has a high enough thermodynamic stability.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9637257     DOI: 10.1016/s0014-5793(98)00463-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

1.  Selection of antibodies for intracellular function using a two-hybrid in vivo system.

Authors:  M Visintin; E Tse; H Axelson; T H Rabbitts; A Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  The rules of variation: amino acid exchange according to the rotating circular genetic code.

Authors:  Fernando Castro-Chavez
Journal:  J Theor Biol       Date:  2010-04-03       Impact factor: 2.691

Review 3.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

4.  Understanding the contribution of disulfide bridges to the folding and misfolding of an anti-Aβ scFv.

Authors:  Laia Montoliu-Gaya; Jose C Martínez; Sandra Villegas
Journal:  Protein Sci       Date:  2017-04-11       Impact factor: 6.725

5.  Module based antibody engineering: a novel synthetic REDantibody.

Authors:  Anatoliy Markiv; Bernard Anani; Ravi V Durvasula; Angray S Kang
Journal:  J Immunol Methods       Date:  2010-11-03       Impact factor: 2.303

6.  Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm.

Authors:  Erik Kvam; Michael R Sierks; Charles B Shoemaker; Anne Messer
Journal:  Protein Eng Des Sel       Date:  2010-04-08       Impact factor: 1.650

7.  Functional expression of a single-chain antibody fragment against human epidermal growth factor receptor 2 (HER2) in Escherichia coli.

Authors:  Vajihe Akbari; Hamid Mir Mohammad Sadeghi; Abbas Jafrian-Dehkordi; Daryoush Abedi; C Perry Chou
Journal:  J Ind Microbiol Biotechnol       Date:  2014-03-27       Impact factor: 3.346

8.  Genetically targeted adenovirus vector directed to CD40-expressing cells.

Authors:  Natalya Belousova; Nikolay Korokhov; Valentina Krendelshchikova; Vera Simonenko; Galina Mikheeva; Pierre L Triozzi; Wayne A Aldrich; Papia T Banerjee; Stephen D Gillies; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies.

Authors:  Shubhada N Joshi; David C Butler; Anne Messer
Journal:  MAbs       Date:  2012-08-28       Impact factor: 5.857

10.  scFv-based "Grababody" as a general strategy to improve recruitment of immune effector cells to antibody-targeted tumors.

Authors:  Zheng Cai; Ting Fu; Yasuhiro Nagai; Lian Lam; Marla Yee; Zhiqiang Zhu; Hongtao Zhang
Journal:  Cancer Res       Date:  2013-02-08       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.